Filgrastim Completed Phase 1 Trials for Childhood Choroid Plexus Tumor / Recurrent Childhood Cerebral Astrocytoma / Childhood Medulloepithelioma / Childhood Central Nervous System Germ Cell Tumor / Recurrent Childhood Cerebellar Astrocytoma / Childhood Low-grade Cerebral Astrocytoma / Childhood Infratentorial Ependymoma / Recurrent Childhood Medulloblastoma / Childhood Grade I Meningioma / Childhood Grade II Meningioma / Recurrent Childhood Pineoblastoma / Recurrent Childhood Subependymal Giant Cell Astrocytoma / Childhood Supratentorial Ependymoma / Childhood Oligodendroglioma / Childhood Ependymoblastoma / Childhood Mixed Glioma / Childhood High-grade Cerebral Astrocytoma / Recurrent Childhood Ependymoma / Recurrent Childhood Visual Pathway and Hypothalamic Glioma / Recurrent Childhood Brain Stem Glioma / Childhood Craniopharyngioma / Childhood High-grade Cerebellar Astrocytoma / Childhood Grade III Meningioma / Childhood Low-grade Cerebellar Astrocytoma / Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00052780Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors